AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS

Rhea-AI Summary

Amgen (NASDAQ:AMGN) has scheduled its third quarter 2024 financial results announcement for Wednesday, October 30, 2024, after U.S. market close. The company will host a conference call at 4:30 p.m. ET featuring Chairman and CEO Robert A. Bradway and senior management. The call will be webcast live and accessible to investors, media, and the public through Amgen's website. The webcast recording will remain available for replay for at least 90 days post-event.

News Market Reaction

+0.41%

1 alert

+0.41% News Effect

On the day this news was published, AMGN gained 0.41%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

THOUSAND OAKS, Calif., Oct. 24, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2024 financial results on Wednesday, October 30, 2024, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen  
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.  

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. 

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads.  

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2024-third-quarter-financial-results-302285159.html

SOURCE Amgen

FAQ

When will Amgen (AMGN) release Q3 2024 earnings?

Amgen will release its third quarter 2024 financial results on Wednesday, October 30, 2024, after the U.S. market close.

What time is Amgen's (AMGN) Q3 2024 earnings call?

Amgen's Q3 2024 earnings conference call is scheduled for 4:30 p.m. ET on October 30, 2024.

How can I access Amgen's (AMGN) Q3 2024 earnings call?

The earnings call can be accessed through a live webcast on Amgen's website (www.amgen.com) under the Investors section.

How long will Amgen's (AMGN) Q3 2024 earnings call replay be available?

The webcast replay will be available for at least 90 days after the event on Amgen's website.